2. Guide for Visitors
  3. Department of Medicine - Gastroenterology and Hepatology

Gastroenterology and Hepatology

Specialized medical services

TAKEHARA Tetsuo Director of Gastroenterology and Hepatology

Director of
Gastroenterology and Hepatology

We treat patients with a wide variety of diseases including hepato-biliary-pancreatic diseases such as chronic hepatitis, cirrhosis, hepatic cancer, and pancreatic cancer, as well as gastrointestinal diseases such as gastrointestinal cancer and inflammatory bowel disease.
We apply the latest treatments to patients with chronic hepatitis C or B with new antivirals, even playing a central role in the world. Patients with hepatic cancer are treated by radiofrequency ablation, transcatheter arterial embolization, and molecular target drugs on an interdisciplinary basis.
We strive to detect esophageal cancer, gastric cancer, and colorectal cancer at the early stage and perform proactively minimally-invasive treatment by endoscopic resection. We conduct clinical studies on the effects of chemotherapy with molecular-target drugs on patients with colorectal cancer and gastrointestinal stromal tumor and on the effects of chemoradiotherapy on patients with esophageal cancer and pancreatic cancer.
We are committed to providing holistic medical care services with respect for patients’ opinions, based on high-quality medical techniques.


We conduct clinical studies: the effects of new antivirals on chronic hepatitis C or B; the effects of molecular target drugs on gastrointestinal stromal tumor and colorectal cancer; the effects of chemoradiotherapy on advanced pancreatic cancer; the effects of radical chemoradiotherapy on esophageal cancer; the effects of molecular target drugs on inflammatory bowel diseases; and the effects of immunosuppressive therapy on ulcerative colitis. Patients with fulminant hepatitis are treated in cooperation with the Trauma and Acute Critical Care Center and hepatic transplantation is also actively performed collaboratively with Gastroenterological Surgery. Endoscopic submucosal dissection is proactively applied to patients with early-stage esophageal cancer, gastric cancer, and colorectal cancer.

More details can be found here (Japanese version only).


Guide for Visitors
Outpatient consultation days
Monday to Friday
Non-consultation days
Saturdays, Sundays, Holidays
New Year’s Holidays:
Dec. 29 to Jan. 3
Consultation times
First visit: 8:30 am to 11:00 am

First-time visitors to Osaka University Hospital must have a referral from a physician.

Revisit: 8:30 am to 11:30 am
Revisit with appointment: 8:30 am to 3:00 pm

Page Top

We cannot answer questions about diseases or treatments by telephone or mail. Please ask in consultation at the hospital.